**1. Introduction**

Peripartum cardiomyopathy (PPCM) is the heart muscle weakness that begins during the late pregnancy and extending into 5 months in puerperium without any other known etiology. PPCM is a dilated cardiomyopathy and involves systolic dysfunction, decreased left ventricular ejection fraction (EF), and congestive heart failure. There is an increased risk of atrial and ventricular arrhythmias and thromboembolism. PPCM is a diagnosis of exclusion, patients have no prior history of heart disease, and there are no other known possible causes of heart failure (HF). Echocardiogram is essentially used for both diagnosis and monitoring purposes in the progress of PPCM. Although initially described in the 18th century, it was recognized as distinct clinical in 1930, and Demakis et al. described and defined PPCM [1]. PPCM was initially termed as pregnancy-associated cardiomyopathy, toxic postpartum heart failure, Meadows' syndrome, postpartum myocarditis, and Zaria syndrome.
